United Therapeutics Corp
NASDAQ:UTHR
United Therapeutics Corp
Cash Taxes Paid
United Therapeutics Corp
Cash Taxes Paid Peer Comparison
Competitive Cash Taxes Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
United Therapeutics Corp
NASDAQ:UTHR
|
Cash Taxes Paid
$337.2m
|
CAGR 3-Years
50%
|
CAGR 5-Years
27%
|
CAGR 10-Years
7%
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Taxes Paid
$1.6B
|
CAGR 3-Years
101%
|
CAGR 5-Years
164%
|
CAGR 10-Years
88%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is United Therapeutics Corp's Cash Taxes Paid?
Cash Taxes Paid
337.2m
USD
Based on the financial report for Mar 31, 2024, United Therapeutics Corp's Cash Taxes Paid amounts to 337.2m USD.
What is United Therapeutics Corp's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 10Y
7%
Over the last year, the Cash Taxes Paid growth was 22%. The average annual Cash Taxes Paid growth rates for United Therapeutics Corp have been 50% over the past three years , 27% over the past five years , and 7% over the past ten years .